Norman Tsui

Norman Tsui is a declared insider of Liberty Biopharma Inc., with filings sourced from SEDI. In total, 3 filings cover trades dated 31 December 2016.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 9 January 2017: a transaction, in Liberty Biopharma Inc. Typically, a trade is published a median of 9 days after it takes place. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.